Therefore, we aimed to provide effective and reliable molecular biological indicators for clinicians to assess the degree of damage and the severity of the disease and predict the disease progression through the detection of BCL-xL level in the blood of newborns with sepsis. Here, BCL2L1 is linked to Sepsis.